LDN Multiple Sclerosis

Dr. Du Moulin has been working with a local compounding pharmacy and the production of an alternative treatment for multiple sclerosis, fibromyalgia, depression, irritable bowel syndrome, and more.

Click on the following link to learn more about the case studies written about how LDN can help control the signs and symptoms associated with multiple sclerosis:

http://www.lowdosenaltrexone.org/ldn_and_ms.htm

Noteworthy Cases

In May 2000, Bernard Bihari, MD reported four occurrences of surprisingly rapid clinical improvement in people with multiple sclerosis, presumably related to LDN use. Three were female patients for whom Dr. Bihari had prescribed nightly LDN.

As of March 2002, all four have sustained the improvement originally seen. Since those four cases were first reported, there have been several dozen more patients who have had similar relief of spasticity allowing better ambulation and relief of MS-related fatigue.

The occurrences Dr. Bihari originally reported in May 2000 were as follows:

1. A 31-year-old patient has a history of relapsing-remitting MS, and recently had developed not only slurred speech and trouble finding the right word (dysphasia) but also had noted weakness in one hand and one leg. She started LDN and reported that within one week her problems with speech had substantially cleared,and there was a marked improvement in her gait and in the use of her hand.
2. The patient who is 44 years old has chronic progressive MS (as do the other two women to be discussed below). She had reached the point some time ago where she needed to use a walker in the home in order to get around. On the third night after starting LDN, she got up and went to the bathroom without using the walker — for the first time in two years. She reports having experienced a prompt 20%-30% improvement in her balance, apparently due to decreased spasticity.
3. The third patient, a woman in her early 50’s, reported prompt improvement in walking within four days after starting LDN, apparently due to decreased spasticity.
4. The fourth case came to Dr. Bihari’s attention in late April 2000 when a woman telephoned his office to leave a message of thanks for him. She has the diagnosis of MS and for the past ten years has had variable visual impairment in one eye, to the extent that she has had to wear eyeglasses to mask that eye. She said her neurologist had begun to prescribe LDN three months earlier. Within two days after starting LDN she regained unimpaired binocular vision. She said that she had recently forgotten to take her LDN at bedtime for two nights in a row, and the eye problem returned — only to subside within a day or two after restarting the medication.